Association of Immune Checkpoint Inhibitors With Neurologic Adverse Events

医学 内科学 不利影响 相对风险 安慰剂 子群分析 食欲不振 随机对照试验 荟萃分析 科克伦图书馆 置信区间 替代医学 病理
作者
Muhammad Zain Farooq,Sheeba Ba Aqeel,Prasanth Lingamaneni,Rayli Carolina Pichardo,Aleeza Jawed,Saad Khalid,Shristi Upadhyay Banskota,Pingfu Fu,Ankit Mangla
出处
期刊:JAMA network open [American Medical Association]
卷期号:5 (4): e227722-e227722 被引量:4
标识
DOI:10.1001/jamanetworkopen.2022.7722
摘要

Neurologic adverse events (NAEs) due to immune checkpoint inhibitors (ICIs) can be fatal but are underexplored.To compare NAEs reported in randomized clinical trials (RCTs) of US Food and Drug Administration-approved ICIs with other forms of chemotherapy and placebo.Bibliographic databases (Embase, Ovid, MEDLINE, and Scopus data) and trial registries (ClinicalTrials.gov) were searched from inception through March 1, 2020.Phase II/III RCTs evaluating the use of ICIs were eligible for inclusion. Unpublished trials were excluded from the analysis.Two investigators independently performed screening of trials using the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guideline. NAEs were recorded for each arm. Data were pooled using a random-effects model.The risk of NAEs with ICI use compared with any drug regimen, cytotoxic chemotherapy, and placebo.A total 39 trials including 23 705 patients were analyzed (16 135 [68.0%] men, 7866 [33.1%] White). The overall risk of a NAE was lower in the ICI group (risk ratio [RR], 0.59; 95% CI, 0.45-0.77) and in the subgroup of RCTs comparing ICI use with chemotherapy (RR, 0.22; 95% CI, 0.13-0.39). In the subgroup of RCTs comparing ICI with placebo, the overall risk of NAE was significantly higher in the ICI group (RR, 1.57; 95% CI, 1.30-1.89). Peripheral neuropathy (RR, 0.30; 95% CI, 0.17-0.51) and dysgeusia (RR, 0.41; 95% CI, 0.27-0.63) were significantly lower in the ICI group. Headache was more common with the use of ICIs (RR, 1.32; 95% CI, 1.10-1.59). In the subgroup analysis of RCTs comparing ICI use with chemotherapy, peripheral neuropathy (RR, 0.09; 95% CI, 0.05-0.17), dysgeusia (RR, 0.42; 95% CI, 0.21-0.85), and paresthesia (RR, 0.29; 95% CI, 0.13-0.67) were significantly lower in the ICI group. RCTs comparing ICIs with placebo showed a higher risk of headache with ICI use (RR, 1.63; 95%, CI, 1.32-2.02).Results of this meta-analysis suggest that the overall risk of NAEs, peripheral neuropathy, and dysgeusia is lower with the use of ICI. When compared with chemotherapy, the overall risk of NAE, peripheral neuropathy, paresthesia, and dysgeusia was lower with ICI use; however, when compared with placebo, the risk of NAEs is higher with the use of ICI.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小马甲应助结实星星采纳,获得10
1秒前
北极星发布了新的文献求助10
1秒前
彩色的若南完成签到,获得积分10
2秒前
2秒前
彭于晏应助蒸蒸日上采纳,获得10
3秒前
3秒前
lalala应助stuckinrain采纳,获得10
3秒前
orixero应助研友_85YNe8采纳,获得10
4秒前
Lucas应助Anaero采纳,获得10
4秒前
OliverW完成签到,获得积分10
6秒前
情怀应助结实星星采纳,获得10
6秒前
北极星完成签到,获得积分10
7秒前
7秒前
clearsky发布了新的文献求助30
7秒前
8秒前
11秒前
小王同学完成签到,获得积分10
11秒前
11秒前
乐乐应助默默的飞烟采纳,获得10
11秒前
lalala应助涨涨涨采纳,获得20
12秒前
左丘世立发布了新的文献求助10
15秒前
15秒前
17秒前
17秒前
要文献啊完成签到 ,获得积分10
18秒前
天真的青完成签到,获得积分20
18秒前
lalala应助ohooo采纳,获得20
18秒前
普通人发布了新的文献求助10
18秒前
FashionBoy应助能HJY采纳,获得10
18秒前
我们完成签到,获得积分10
19秒前
爆米花应助文献下载中采纳,获得10
20秒前
21秒前
大个应助我们采纳,获得10
22秒前
狂野萤应助丰富伯云采纳,获得10
23秒前
23秒前
Jasper应助swq采纳,获得10
23秒前
XuYe驳回了酷波er应助
24秒前
研友_85YNe8发布了新的文献求助10
25秒前
水若冰寒完成签到,获得积分10
25秒前
hins完成签到,获得积分10
27秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Very-high-order BVD Schemes Using β-variable THINC Method 870
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Development of general formulas for bolted flanges, by E.O. Waters [and others] 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3256496
求助须知:如何正确求助?哪些是违规求助? 2898727
关于积分的说明 8301929
捐赠科研通 2567817
什么是DOI,文献DOI怎么找? 1394748
科研通“疑难数据库(出版商)”最低求助积分说明 652913
邀请新用户注册赠送积分活动 630602